Short Interest in OraSure Technologies, Inc. (NASDAQ:OSUR) Expands By 17.2%

OraSure Technologies, Inc. (NASDAQ:OSUR) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,910,000 shares, an increase of 17.2% from the January 15th total of 1,630,000 shares. Based on an average trading volume of 879,000 shares, the short-interest ratio is currently 2.2 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Thursday.

Institutional Trading of OraSure Technologies

Large investors have recently bought and sold shares of the company. Jane Street Group LLC lifted its stake in OraSure Technologies by 37.3% during the fourth quarter. Jane Street Group LLC now owns 406,766 shares of the medical instruments supplier’s stock worth $1,468,000 after purchasing an additional 110,572 shares during the last quarter. Northern Trust Corp lifted its holdings in OraSure Technologies by 6.7% in the 4th quarter. Northern Trust Corp now owns 693,887 shares of the medical instruments supplier’s stock worth $2,505,000 after purchasing an additional 43,628 shares during the last quarter. Tudor Investment Corp ET AL increased its position in OraSure Technologies by 9.7% in the 4th quarter. Tudor Investment Corp ET AL now owns 260,851 shares of the medical instruments supplier’s stock worth $942,000 after buying an additional 23,121 shares during the period. Boothbay Fund Management LLC bought a new stake in shares of OraSure Technologies during the fourth quarter valued at approximately $42,000. Finally, Nebula Research & Development LLC increased its position in shares of OraSure Technologies by 82.3% during the fourth quarter. Nebula Research & Development LLC now owns 71,645 shares of the medical instruments supplier’s stock valued at $259,000 after purchasing an additional 32,340 shares during the period. Institutional investors and hedge funds own 93.50% of the company’s stock.

OraSure Technologies Trading Up 1.0 %

NASDAQ:OSUR traded up $0.04 during trading hours on Friday, hitting $3.93. The stock had a trading volume of 356,731 shares, compared to its average volume of 831,436. OraSure Technologies has a 1-year low of $3.52 and a 1-year high of $8.04. The business has a 50 day simple moving average of $3.81 and a two-hundred day simple moving average of $4.04. The company has a market cap of $293.14 million, a PE ratio of 26.20 and a beta of 0.05.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.